Stacy J. Kanter - Jun 3, 2022 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Role
Director
Signature
/s/ Shoshana Shendelman, as attorney-in-fact
Stock symbol
APLT
Transactions as of
Jun 3, 2022
Transactions value $
$0
Form type
4
Date filed
6/7/2022, 09:20 PM
Previous filing
Jun 4, 2021
Next filing
Aug 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLT Stock Option (Right to Buy) Award $0 +16.5K $0.00 16.5K Jun 3, 2022 Common Stock 16.5K $1.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of Options granted to directors under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-twelfth (1/12th) of the shares subject to the Option shall vest on July 2, 2022 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date.